Bank of Montreal
GNOM icon

Bank of Montreal’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Bank of Montreal’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-31
Closed -$2 – 4096
2022
Q3 		$2 Sell
31
-100
-76% -$5.64K ﹤0.01% 3985
2022
Q2 		$7 Hold
131
– – ﹤0.01% 3898
2022
Q1 		$8K Buy
131
+100
+323% +$6.31K ﹤0.01% 4016
2021
Q4 		$3K Hold
31
– – ﹤0.01% 3436
2021
Q3 		$3K Hold
31
– – ﹤0.01% 3768
2021
Q2 		$3K Hold
31
– – ﹤0.01% 3600
2021
Q1 		$3K Buy
+31
New +$3.06K ﹤0.01% 4818

Other funds holding GNOM

Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
OCM
One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
SWA
Sightline Wealth Advisors Groton, Connecticut $273M AUM 18.08% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Bank of Montreal's GNOM Position: Q4 2022 in Review

Bank of Montreal sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q4 2022, closing a stake of 31 shares — an estimated $2 sold.

Bank of Montreal first reported a position in GNOM in Q1 2021 and held it in 7 quarters. The position peaked at $8K in Q1 2022. 65 funds tracked by Wall St. Rank hold GNOM as of Q4 2022.

  • Bank of Montreal reported no remaining Global X Genomics & Biotechnology ETF position as of Q4 2022 after selling out during the quarter.
  • Bank of Montreal sold 31 Global X Genomics & Biotechnology ETF shares in Q4 2022, an estimated $2.
  • Bank of Montreal first reported a position in Global X Genomics & Biotechnology ETF in Q1 2021 and held it in 7 quarters.
  • Bank of Montreal's Global X Genomics & Biotechnology ETF position peaked at $8K in Q1 2022.
  • 65 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q4 2022.

Based on Bank of Montreal's 13F filing for Q4 2022, filed 1 Feb 2023.